Arrowhead Research Corporation (ARWR) to Present at Upcoming Scientific Conferences
6/14/2013 7:02:53 AM
More...
|
Arrowhead Research Corporation (ARWR) Files to Begin Phase 1 Trial of RNAi Therapeutic ARC-520 Against Chronic Hepatitis B Infection
5/28/2013 9:46:52 AM
More...
|
Arrowhead Research Corporation (ARWR) to Present at Upcoming Scientific Conferences
5/13/2013 7:22:46 AM
More...
|
Arrowhead Research Corporation (ARWR) Reports Fiscal 2013 Second Quarter Financial Results
5/10/2013 7:39:53 AM
More...
|
Arrowhead Research Corporation (ARWR) Receives Patent Allowance for DPC siRNA Delivery System With Peptide Backbone
5/7/2013 11:13:54 AM
More...
|
Arrowhead Research Corporation (ARWR) Closes $36 Million Private Offering
5/6/2013 7:22:28 AM
More...
|
Arrowhead Research Corporation (ARWR) to Report Fiscal 2013 Second Quarter Financial Results
5/2/2013 8:15:23 AM
More...
|
Arrowhead Research Corporation (ARWR) to Present at Needham Healthcare Conference
4/25/2013 8:05:07 AM
More...
|
Arrowhead Research Corporation (ARWR) Induces 90% Reduction in Hepatitis B Antigens in Chimpanzee With Chronic Infection: Data Follow Previous Report of Reduction in Viral DNA
3/25/2013 9:33:48 AM
More...
|
Arrowhead Research Corporation (ARWR) Receives Notice of Patent Allowance for New Protease Sensitive Masking Chemistry for DPC siRNA Delivery System
2/28/2013 9:56:28 AM
More...
|
|